| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.0035 | 1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |